254 related articles for article (PubMed ID: 37762693)
1. A Route for Investigating Psoriasis: From the Perspective of the Pathological Mechanisms and Therapeutic Strategies of Cancer.
Wu X; Ma Y; Wang L; Qin X
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762693
[TBL] [Abstract][Full Text] [Related]
2. Piperlongumine regulates epigenetic modulation and alleviates psoriasis-like skin inflammation via inhibition of hyperproliferation and inflammation.
Thatikonda S; Pooladanda V; Sigalapalli DK; Godugu C
Cell Death Dis; 2020 Jan; 11(1):21. PubMed ID: 31924750
[TBL] [Abstract][Full Text] [Related]
3. PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: a possible cellular basis for remittive therapy.
Vallat VP; Gilleaudeau P; Battat L; Wolfe J; Nabeya R; Heftler N; Hodak E; Gottlieb AB; Krueger JG
J Exp Med; 1994 Jul; 180(1):283-96. PubMed ID: 7516410
[TBL] [Abstract][Full Text] [Related]
4. Research Note Mesenchymal stem cells from skin lesions of psoriasis patients promote proliferation and inhibit apoptosis of HaCaT cells.
Liu RF; Wang F; Wang Q; Zhao XC; Zhang KM
Genet Mol Res; 2015 Dec; 14(4):17758-67. PubMed ID: 26782421
[TBL] [Abstract][Full Text] [Related]
5. Phosphodiesterase 7A inhibitor ASB16165 impairs proliferation of keratinocytes in vitro and in vivo.
Goto M; Kadoshima-Yamaoka K; Murakawa M; Yoshioka R; Tanaka Y; Inoue H; Murafuji H; Kanki S; Hayashi Y; Nagahira K; Ogata A; Nakatsuka T; Fukuda Y
Eur J Pharmacol; 2010 May; 633(1-3):93-7. PubMed ID: 20132810
[TBL] [Abstract][Full Text] [Related]
6. Chrysin alleviates imiquimod-induced psoriasis-like skin inflammation and reduces the release of CCL20 and antimicrobial peptides.
Li HJ; Wu NL; Pu CM; Hsiao CY; Chang DC; Hung CF
Sci Rep; 2020 Feb; 10(1):2932. PubMed ID: 32076123
[TBL] [Abstract][Full Text] [Related]
7. Epidermal activation of the small GTPase Rac1 in psoriasis pathogenesis.
Winge MCG; Marinkovich MP
Small GTPases; 2019 May; 10(3):163-168. PubMed ID: 28055293
[TBL] [Abstract][Full Text] [Related]
8. Implications of LncRNAs and CircRNAs in psoriasis: a review.
Shi R; Ma R; Jiang X; Tang X; Gong Y; Yu Z; Shi Y
RNA Biol; 2023 Jan; 20(1):334-347. PubMed ID: 37310201
[TBL] [Abstract][Full Text] [Related]
9. The Long Noncoding RNA LINC00958 Is Induced in Psoriasis Epidermis and Modulates Epidermal Proliferation.
Luo L; Pasquali L; Srivastava A; Freisenhausen JC; Pivarcsi A; Sonkoly E
J Invest Dermatol; 2023 Jun; 143(6):999-1010. PubMed ID: 36641130
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of danshensu-induced inhibition of abnormal epidermal proliferation in psoriasis.
Jia J; Mo X; Liu J; Yan F; Wang N; Lin Y; Li H; Zheng Y; Chen D
Eur J Pharmacol; 2020 Feb; 868():172881. PubMed ID: 31866405
[TBL] [Abstract][Full Text] [Related]
11. Indirubin attenuates mouse psoriasis-like skin lesion in a CD274-dependent manner: an achievement of RNA sequencing.
Xue X; Wu J; Li J; Xu J; Dai H; Tao C; Li C; Hu J
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30341238
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-181b negatively regulates the proliferation of human epidermal keratinocytes in psoriasis through targeting TLR4.
Feng C; Bai M; Yu NZ; Wang XJ; Liu Z
J Cell Mol Med; 2017 Feb; 21(2):278-285. PubMed ID: 27641447
[TBL] [Abstract][Full Text] [Related]
13. RAC1 activation drives pathologic interactions between the epidermis and immune cells.
Winge MC; Ohyama B; Dey CN; Boxer LM; Li W; Ehsani-Chimeh N; Truong AK; Wu D; Armstrong AW; Makino T; Davidson M; Starcevic D; Kislat A; Nguyen NT; Hashimoto T; Homey B; Khavari PA; Bradley M; Waterman EA; Marinkovich MP
J Clin Invest; 2016 Jul; 126(7):2661-77. PubMed ID: 27294528
[TBL] [Abstract][Full Text] [Related]
14. The Keratinocyte Transcriptome in Psoriasis: Pathways Related to Immune Responses, Cell Cycle and Keratinization.
Pasquali L; Srivastava A; Meisgen F; Das Mahapatra K; Xia P; Xu Landén N; Pivarcsi A; Sonkoly E
Acta Derm Venereol; 2019 Feb; 99(2):196-205. PubMed ID: 30320872
[TBL] [Abstract][Full Text] [Related]
15. Increased presence and differential molecular imprinting of transit amplifying cells in psoriasis.
Witte K; Jürchott K; Christou D; Hecht J; Salinas G; Krüger U; Klein O; Kokolakis G; Witte-Händel E; Mössner R; Volk HD; Wolk K; Sabat R
J Mol Med (Berl); 2020 Jan; 98(1):111-122. PubMed ID: 31832701
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-17A and Keratinocytes in Psoriasis.
Furue M; Furue K; Tsuji G; Nakahara T
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32070069
[TBL] [Abstract][Full Text] [Related]
17. EZH2-dependent epigenetic modulation of histone H3 lysine-27 contributes to psoriasis by promoting keratinocyte proliferation.
Zhang T; Yang L; Ke Y; Lei J; Shen S; Shao S; Zhang C; Zhu Z; Dang E; Wang G
Cell Death Dis; 2020 Oct; 11(10):826. PubMed ID: 33011750
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of CtBP-Regulated Proinflammatory Gene Transcription Attenuates Psoriatic Skin Inflammation.
Li H; Zhang C; Bian L; Deng H; Blevins M; Han G; Fan B; Yang C; Zhao R; High W; Norris D; Fujita M; Wang XJ; Huang M
J Invest Dermatol; 2022 Feb; 142(2):390-401. PubMed ID: 34293351
[TBL] [Abstract][Full Text] [Related]
19. Valrubicin in a topical formulation treats psoriasis in a xenograft transplantation model.
Rosada C; Stenderup K; de Darkó E; Dagnaes-Hansen F; Kamp S; Dam TN
J Invest Dermatol; 2010 Feb; 130(2):455-63. PubMed ID: 19741712
[TBL] [Abstract][Full Text] [Related]
20. The significance of endocan immunohistochemical expression in chronic plaque psoriasis.
Abdou AG; Hammam M; Saad E; Hassan RAA
J Cosmet Dermatol; 2022 Jan; 21(1):380-386. PubMed ID: 33742537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
